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Abstract
Public perceptions of pandemic viral threats and government policies can influence adher-
ence to containment, delay, and mitigation policies such as physical distancing, hygienic
practices, use of physical barriers, uptake of testing, contact tracing, and vaccination pro-
grams. The UK COVID-19 Public Experiences (COPE) study aims to identify determinants
of health behaviour using the Capability, Opportunity, Motivation (COM-B) model using a
longitudinal mixed-methods approach. Here, we provide a detailed description of the demo-
graphic and self-reported health characteristics of the COPE cohort at baseline assess-
ment, an overview of data collected, and plans for follow-up of the cohort. The COPE
baseline survey was completed by 11,113 UK adult residents (18+ years of age). Baseline
data collection started on the 13th of March 2020 (10-days before the introduction of the first
national COVID-19 lockdown in the UK) and finished on the 13th of April 2020. Participants
were recruited via the HealthWise Wales (HWW) research registry and through social
media snowballing and advertising (Facebook®, Twitter®, Instagram®). Participants were
predominantly female (69%), over 50 years of age (68%), identified as white (98%), and
were living with their partner (68%). A large proportion (67%) had a college/university level
education, and half reported a pre-existing health condition (50%). Initial follow-up plans for
PLOS ONE







Citation: Phillips R, Taiyari K, Torrens-Burton A,
Cannings-John R, Williams D, Peddle S, et al.
(2021) Cohort profile: The UK COVID-19 Public
Experiences (COPE) prospective longitudinal
mixed-methods study of health and well-being
during the SARSCoV2 coronavirus pandemic.
PLoS ONE 16(10): e0258484. https://doi.org/
10.1371/journal.pone.0258484
Editor: Ismaeel Yunusa, University of South
Carolina College of Pharmacy, UNITED STATES
Received: July 9, 2021
Accepted: September 28, 2021
Published: October 13, 2021
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pone.0258484
Copyright: © 2021 Phillips et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data cannot be
shared publicly because of the data is of a detailed
the cohort included in-depth surveys at 3-months and 12-months after the first UK national
lockdown to assess short and medium-term effects of the pandemic on health behaviour
and subjective health and well-being. Additional consent will be sought from participants at
follow-up for data linkage and surveys at 18 and 24-months after the initial UK national lock-
down. A large non-random sample was recruited to the COPE cohort during the early stages
of the COVID-19 pandemic, which will enable longitudinal analysis of the determinants of
health behaviour and changes in subjective health and well-being over the course of the
pandemic.
Introduction
The COVID-19 pandemic is having a profound and wide-reaching effect on societies globally
[1]. Public perceptions of pandemic viral threats and government policies can influence adher-
ence to containment, delay, and mitigation policies such as physical distancing, hygienic prac-
tices, use of physical barriers (such as face coverings, face shields, protective clothing, and
disposable gloves), and uptake of testing, contact tracing, and vaccination programs [2–14].
There are marked social inequalities in the risk of harm to health and well-being during the
COVID-19 pandemic, particularly in relation to ethnicity, occupational status, social depriva-
tion, sex, housing, and pre-existing physical and mental-health conditions [15–18]. Under-
standing the impact of the pandemic and related policies on physical health and psychological
well-being is a high priority for government and public health agencies [1, 19]. Timely, high-
quality research that adopts a holistic approach to behaviour, health, and well-being is needed
to inform the immediate response to and long-term recovery from the COVID-19 pandemic
[1, 18].
The COVID-19 UK Public Experiences (COPE) study is a prospective longitudinal mixed-
methods study that was established during the early stages of the pandemic outbreak, which
aimed to build a detailed understanding of health behaviour and health and well-being out-
comes over the course of the pandemic [20]. The Capability, Opportunity, Motivation model
of behaviour (COM-B) model was selected as the conceptual model for the COPE study to
provide a systematic method for identifying potentially modifiable determinants of health
behaviour. The COM-B forms a core part of the Behaviour Change Wheel (BCW) framework
for the development and evaluation of complex behaviour change intervention, enabling map-
ping of determinants of behaviour to classes of intervention and specific behaviour change
techniques [21]. The COM-B is an integrated model that takes into account multiple factors
that can influence behaviour, such as knowledge, beliefs, attitudes, and practical barriers and
facilitators in understanding health behaviour [21]. The COM-B has been used to explain a
range of infection-related health behaviour, including hand hygiene, environmental disinfec-
tion, use of personal protective equipment (PPE), uptake of screening and testing, use of anti-
virals and antibiotics for respiratory tract infections, uptake of influenza vaccines, and lifestyle
behaviour in the context of respiratory tract infection outbreaks [10, 13, 22–44].
Infection-transmission prevention behaviours, including hygiene behaviours, social dis-
tancing, use of physical barriers, and uptake of vaccinations (when they became available)
were of primary interest in the COPE study. The COM-B provided a useful framework for
understanding the complex relationship between multiple determinants of infection-transmis-
sion prevention behaviour and the wider social, political, and environmental context [11].
Based on research in previous pandemics [45–47], it was anticipated that psychological
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capability (e.g., knowledge and skills), opportunity (e.g., physical and social environment), and
motivation (e.g., attitudes, appraisal of risk, fear) were potentially important determinants of
these behaviours. The COM-B has also been applied to understanding changes in health
behaviour more generally, such as physical activity, in the context of a pandemic [41]. Key
health behaviours, including physical activity, healthy eating, smoking, alcohol use, socializing,
relaxing activities, and health service use were also of interest in the COPE study due to the
likely disruption of these behaviours in the context of the pandemic and the potential impact
on health and well-being outcomes [20]. In terms of identifying determinants of these behav-
iours over the course of the pandemic, we were particularly interested in the effects of social
and physical environment (opportunity) and whether the perceived seriousness of the
COVID-19 threat increased or decreased engagement with health promoting behaviour
(motivation).
This paper describes the initial profile of the COPE study online cohort, providing an over-
view of the collected data, a description of the initial demographic and self-reported health
characteristics of the population reported during the baseline assessment, and detailing plans
for follow-up of the cohort.
Materials and methods
Design
The COPE study is a longitudinal mixed-methods prospective cohort study [20]. The COM-B
model was used to identify potential determinants of infection-transmission prevention
behaviour and key health behaviours during the COVID-19 pandemic. This informed the
selection of measures at each data collection point, provided a framework for planning analysis
and data triangulation, facilitated interpretation of findings, and provided a systematic method
for identifying potential opportunities for interventions.
Setting
The COPE study focused on understanding health behaviour over the course of the COVID-
19 pandemic in a UK community setting. The World Health Organization (WHO) declared
the COVID-19 outbreak a pandemic on the 11th of March 2020 [48]. On the 13th of March
2020 when the COPE baseline survey was launched, within the UK there had been 480 con-
firmed cases and 16 reports of people having died within 28 days of having had a positive
COVID-19 test (Fig 1). When the COPE baseline survey closed on the 13th of April 2020, there
had been 4,168 confirmed COVID-19 cases and 895 deaths within 28 days of a positive
COVID-19 test in the UK [49]. Globally, there had been 533,132 confirmed cases of COVID-
19 and 51,585 deaths by the time the COPE baseline survey closed [50].
Cohort recruitment
The COPE cohort was recruited through a baseline online survey. Recruitment occurred via
two routes:
1. A multi-faceted sampling method based on convenience sampling, snowballing, and pur-
posive sampling via social media. We created dedicated Facebook1 (@COVID19publicex-
periencesUK), Instagram1 (@COVID19publics1) and Twitter1 (@COVID19publics1)
feeds, and a study website (https://copestudy.yolasite.com) to publicise the study. Through
these, we regularly posted information about the study and invitations to take part in the
baseline survey, which included a hyperlink to the online survey. Social media feeds were
regularly monitored and moderated. Facebook and Instagram’s paid promotion feature
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was used to boost posts. Based on research in previous pandemics, we anticipated that key
demographic variables, such as age, gender, and education, were likely to be associated with
the impact that the pandemic had on individuals and on their responses to the pandemic
[3, 51, 52]. It became clear during the early stages of recruitment that men and younger age
groups were under-represented in our cohort, so we tailored as recruitment progressed to
focus on using our finite resources to increase our reach with these demographic groups
(total advertising budget for the study, £150).
2. From the 20th of March onwards, the study was advertised via HealthWise Wales (HWW)
[53], a national population survey and research register of participants who live or receive
healthcare in Wales. Invitations to take part were e-mailed to HWW participants on two
occasions, providing a summary of the COPE study and a hyperlink to the survey.
Follow-up procedures for the longitudinal cohort study
Longitudinal survey data collection points. There was much uncertainty about the
course of the pandemic when the study was launched. A balance needed to be found between
the need to capture detailed, comprehensive data without over-burdening participants. There-
fore, survey data collection at three static time points were planned for the COPE Study in the
first instance. The baseline survey took place between the 13th of March and the 13th of April
2020, as the first wave of COVID-19 was occurring in the UK and lockdown measures were
coming into force. Follow-up surveys were planned at three months (June/July 2020) and 12
months (March/April 2021) after the initial lockdown to provide data on short- and medium-
term changes in behaviour and health and well-being outcomes. Our three-month survey data
collection point coincided with the initial easing of lockdown restriction after the peak of the
first wave in the UK had subsided. The 12-month data collection point occurred following a
second wave and prolonged lockdown period in the UK, while restrictions were slowly being
eased and a mass vaccination program was underway. As the pandemic progressed, it became
clear that there would be a significant longer-term impact on health and well-being of the gen-
eral population, and that the recovery phase had not been reached by the 12-month follow-up
survey. Therefore, data linkage with electronic health record (EHR) data sources and HWW
data, and further survey data collection points at 18 and 24-months after the initial UK
Fig 1. Number of participants completing the COPE survey via the HealthWise Wales (HWW) and social media
(SM) routes on each day of the baseline recruitment period.
https://doi.org/10.1371/journal.pone.0258484.g001
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lockdown were added to the study protocol to enable longer-term behavioural and health and
well-being outcomes to be assessed.
Data collection procedure. Baseline data were collected using the Onlinesurveys.ac.uk
platform. Participants who consented to follow-up provided their e-mail address and/or a tele-
phone number. Follow-up data will be collected using Qualtrics.com for pragmatic reasons.
Participants were sent an individualised link to their e-mail or mobile phone which recorded a
unique study identification number alongside responses to enable data linkage from each time
point to take place. At each follow-up point, participants were sent an initial invitation and
non-responders received a maximum of two reminders.
Measures
The COM-B model was used to inform the selection of measures for this study, with regular
review of measures as the pandemic progressed based on information gathered via the qualitative
component of the COPE study, feedback from the study patient and public involvement partners,
and the shifting pandemic, policy, and social context. A summary of topics covered at each time
point is provided in Table 1. S2 File provides details of all items included in the surveys along
with citations for the original source of items/scales where applicable. Further information on the
development of the surveys and specific measures included at each time point is provided in the
study protocol [20]. In this article, we focus on characterising the COPE cohort at the baseline
assessment in terms of key demographic characteristics and self-reported health.
Demographic data. Data were collected at baseline on age category, gender, highest level
of education, ethnicity, marital status, and caring responsibilities (children under 18-years of
age, children under the age of 5-years, children with pre-existing health conditions, adults with
pre-existing health conditions, older adults).
Self-reported health and well-being. To assess perceived exposure to COVID-19, partici-
pants were asked whether they had or thought they may have had COVID-19, and whether
they had experienced the key symptoms of COVID-19 that had been identified in the early
stages of the pandemic (continuous cough, fever, loss of taste or smell). Participants were
asked whether they had pre-existing medical conditions, which conditions these were, and
whether they had received a seasonal flu vaccination in the last 12-months.
Four items were included from the SF12v1 measure [54] to assess general health and mental
health. The general health item was scored from 1 = poor to 6 = excellent. Subjective well-
being was measured using three items to assess vitality; “Did you have a lot of energy?”, and
mental health; “Have you felt calm and peaceful?”, “Have you felt downhearted and blue”
(reversed). The summed score of the two mental health items has been found to be a useful
screening tool in the general population for affective disorders [55].
Data analyses. Recruitment of participants through HWW and social media on each day that
the baseline survey was open was mapped against key events relating to COVID-19 in the UK to
provide the context for data collected within a rapidly changing situation. Descriptive analysis of the
baseline demographic characteristics, self-reported health and well-being was carried out for partici-
pants overall, and for those joining the COPE cohort from each of the recruitment routes (HWW
and social media) to provide a detailed profile of the cohort. Population data for Wales and the UK
was gathered from published sources to enable us to understand which demographic groups may
be over- or under-represented in the COPE cohort. Analyses were conducted in SPSSv27.
Patient and public involvement (PPI)
Members of the public were consulted informally to comment on the online baseline survey
design, which needed to be developed rapidly before we had secured any external funding for
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the project. We subsequently invited expressions of interest in joining the study team from the
Centre for Trials Research and PRIME Centre PPI panels and two members of the public for-
mally joined our research team. They commented on the design of the study, including the
survey and interview questions in each phase, were co-applicants on the funding application,
and are included as co-authors on key study outputs (including for this manuscript), and will
support wider dissemination of findings as the research progresses.
Ethics and governance
Ethical approval was obtained for the COPE Study from the Cardiff Metropolitan University
Applied Psychology ethics panel on 13.3.20 (Project reference Sta-2707). Participants provided








COVID-19 transmission-prevention behaviour (including physical distancing, hygiene,
and use of physical barriers)
X X X
Health behaviour (including smoking, diet, alcohol, physical activity, social contact,
relaxing activities)
X X X
COVID-19 vaccination uptake X
COVID-19 testing and self-isolation X
Capability
COVID-19 knowledge and information needs X
Sources of information on COVID-19 accessed and perceived reliability of these sources X X X




COVID-19 risk perception (perceived susceptibility, harmfulness, worry and attention) X X X
Self-efficacy for reducing COVID-19 transmission X X
Perceived barriers and facilitators to engaging in infection-transmission prevention
behaviour
X X X
Attitudes towards COVID-19 vaccination X X
Attitudes towards COVID-19 community testing and contact tracing X
Attitudes towards self-isolation X
Opportunity (social and physical environment)
Sex, age, pre-existing medical conditions, education, religion, ethnic group, sexual
orientation
X
Employment status X X X
Caring responsibilities X X
Neighbourhood cohesion Xa X
Perceived access to green spaces Xa
Work environment X X X
Bereavement Xa
Patient-reported healthcare experiences (including patient-reported safety concerns) Xa X
Health and well-being outcomes
COVID-19 incidence & symptoms X X X
Subjective physical and mental health: Four items from the 12-item version of the Short-
Form Health Survey (SF12v1) [54] at all time points.
X X X
Patient Health Questionnaire (PHQ-4) added at 3 and 12-month follow-up.
aIncluded as optional modules in the 3-month follow-up survey.
https://doi.org/10.1371/journal.pone.0258484.t001
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consent and confirmed eligibility electronically at the beginning of the baseline survey and
provided consent to re-contact at the end of the survey. Additional consent was sought from
participants recruited via HWW at 3 and 12-month follow up for linkage their COPE data
with data held by HWW and their electronic healthcare records (EHRs) at 3 and 12-month fol-
low up (Project Sta-2707, amendment 2, approved 11.6.2020). Participants were asked for con-
sent to recontact for longer-term follow-up during the 12-month survey (Project Sta-2707,
amendment 3, approved 5.3.2021). The HWW research database received favourable ethical
reviews 15_WA_0076 and 20_WA_0064. An application from COPE Cymru to access HWW
data on mutual participants (with participant consent) within the Secure Protected Portal and
HWW Resource SAPPHIRe was approved on 06/02/21. Approvals for provision of healthcare
data to HWW relevant to the COPE were granted by an independent Information Governance
Review Panel (IGRP) under project 0415 HWW on 15/12/20 and 02/03/21.
Findings to date
Baseline cohort characteristics. 11,113 people took part in the baseline COPE survey
between March 13th and April 12th 2020. Recruitment for the baseline survey took place during
a time of rapid change in infection rates and government policy, as illustrated in Fig 1.
The majority of the COPE cohort were recruited through HWW (n = 8,726, 79%) and as
such were resident or receiving healthcare in Wales. An additional n = 2,386 (21%) recruited
via social media (UK-wide). A summary of baseline characteristics of the COPE cohort is pro-
vided in Table 2. Table 2 also provides a summary of Welsh and UK population data available
from published sources to enable comparison of the COPE cohort with the general population
and identification of under-represented demographic groups within our cohort.
Females (69%), people over 60 years of age (68%), those who were married or in a civil part-
nership, (58%) and those who had achieved a higher education qualification (67%) were over-
represented in the sample. With the majority of our sample being in Wales, 98% reported
being white, which was similar to the Welsh population (96% white) [56]. Half of the COPE
cohort reported a pre-existing health condition (51%), which was slightly higher than in the
Welsh population (48%) where there are higher rates of people living with longstanding condi-
tions than in England (43%). Despite the high rate of pre-existing conditions, self-evaluation
of general health was better in the COPE cohort (81% rating health as good, very good, or
excellent) compared with the Welsh (71%) and English (75%) populations. At least one caring
responsibility for children, adults with a pre-existing health condition and/or older adults
(aged 70+) was reported by 42% of the COPE cohort, and 19% had children aged<18 years
living in the household. Flu vaccination for adults were routinely offered via the NHS in 2019/
2020 to all those aged 65+, those aged<65 who are in clinical at-risk groups, and frontline
health and social care workers. Self-reported flu vaccine uptake in the COPE cohort was lower
than national averages for England and Wales for the 2019–2020 winter season, particularly in
the under 60 age group who reported at least one pre-existing medical condition [57, 58].
There were some differences between participants joining the cohort through the HWW
and social media routes (see S1 Table). There was increased representation from younger age
groups, ethnic minority groups and those reporting caring responsibilities for children under
the age of 18 years in the social media sample compared to the HWW sample. Females repre-
sented an even larger majority (82%) in the social media sample.
Exposure to COVID-19 infection at baseline
In the COPE baseline survey, 347 (3.1%) people thought that they currently or had already had
COVID-19, and 1,799 (16.2%) thought they might have had it. Only 34 (0.3%) people had
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been diagnosed with COVID-19 by a health professional and 13 people (0.2%) had taken a lab-
oratory test for COVID-19 with 6 (0.1%) testing positive for COVID-19. By April 13th 2020
there had been 96,877 confirmed cases of COVID-19 in the UK, representing around 0.15% of
the UK population and the report of positive COVID-19 tests within our cohort was consistent
with this. The COPE baseline data were collected before widespread community testing for
COVID-19 was available in the UK and it is likely that there were more unconfirmed and
asymptomatic cases present during this period in our cohort and the general population than
those confirmed by laboratory testing.
Consent to follow-up
Overall, 9,899 (89.1%) of the 11,113 COPE participants consented to follow-up surveys at the end
of their baseline survey. Rates of consent to follow-up were higher amongst those recruited via
HWW (8,126/8,727, 93.1%) than via social media (1,773/2,386, 74.3%). Consent to contact for
qualitative interviews was provided by 4,833 participants (43.5%). Additional explicit consent for
data linkage with HWW and EHR data will be sought from HWW participants during follow-up
surveys, opening the potential for analysis of pre-pandemic health, well-being, and behavioural
data and long-term follow-up of health outcomes and health service usage in this cohort.
Table 2. COPE cohort baseline characteristics and population data for published sources for Wales and the UK.
Characteristic Population data sources Category COPE cohort
(n = 11,113)
Wales (Population




Sex Stats Wales [56] Male 30 49 49
Female 69 51 51
Other <1 Data not available Data not available
Age group StatsWales [56] Older adults�: 47 26 23
Over 60 years—Welsh and UK population
data age groups
65 years and over–COPE cohort age groups
Ethnicity StatsWales [56], Office for
National Statistics [59]
White 98 96 86
Other 2 4 14
Marital status Office for National
Statistics [60]





People who have achieved a higher
education qualification
67 47 40
Flu vaccination in the
last 12 months�
Public Health England
[57], Public Health Wales
[58]
Adults <60 years with a pre-existing
condition who had received a flu
vaccination
25 44 44��
Older adults who had received a flu
vaccination (COPE aged 60+, UK and




StatsWales [62], Office for
National Statistics [63]







COPE—good, very good, or excellent 81 71 75��
Population data–good or very good
COPE–poor 5 9 7��
Population data—bad or very bad
�COPE age bands and general health self-evaluation categories do not correspond directly to publicly available population data and closest approximation of categories
has been provided.
��Data for England rather than UK.
https://doi.org/10.1371/journal.pone.0258484.t002
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Discussion
The COPE cohort was established during the early stages of the COVID-19 outbreak in the
UK before the initiation of lockdown and the likely impact of the pandemic was known. Over
11,000 people were recruited into the cohort during the baseline survey, with 89.1% consenting
to follow-up. The COPE study was designed by a multi-disciplinary team using an established
theoretical framework, the COM-B model, to guide the measures used, analysis and interpreta-
tion of findings. Our analysis at each survey time point will be considered within the context
of local, national and international policy and infection rates [49, 50, 65, 66], and major themes
identified in mainstream media at the time of data collection. This will enable us to build a
detailed understanding of health behaviour and subjective health and well-being in this cohort
as the pandemic progresses.
Future plans
Analysis of the cross-sectional and longitudinal data collected from this cohort will be conducted
to identify the characteristics of people who have low engagement with infection-transmission
prevention behaviour at different stages in the pandemic, with an emphasis on understanding the
role of COVID-19 risk perception in determining behaviour. We will examine broader changes
in lifestyle, health and well-being to identify groups that may be in need of additional support dur-
ing lockdown periods, and to inform the design and implementation of interventions to promote
health, well-being and re-engagement with social roles during the recovery phase.
Tailored behavioural measures needed to be developed and adapted as the pandemic pro-
gressed to capture data on relevant and emerging issues, such as community testing, contact
tracing, vaccination, and patient safety. Data from the 3-month follow-up survey (not pre-
sented here) will be analysed to investigate the factor structure and conduct validation of the
behavioural measures used in this study. Establishing what is ‘appropriate’ behaviour at differ-
ent stages of the pandemic will also be considered during analysis and interpretation of find-
ings, as people will need to adjust their behaviour as the seriousness of the COVID-19 threat
shifts and lockdown restrictions tighten and relax over the course of the pandemic. As well as
our pre-planned analyses, we will draw on evidence from the rapidly growing body of research
on behaviour, risk perception, and health behaviour and well-being during the COVID-19
pandemic to inform additional analyses of our data and to enable us to interpret our findings
in the context of the wider literature [e.g. 1, 8, 11, 12, 41, 67–81].
Public and patient involvement in research is essential in ensuring that research is relevant
to participants, designed in a way that is acceptable to people taking part, and improves the
communication of results to participants as they become available [82]. Public involvement in
this study has been essential to designing questionnaires and interview schedules that are rele-
vant and acceptable to participants, designing information sheets and consent procedures, and
communicating findings of this research. We will continue to involve our patient and public
partners who are joint grant-holders for this project and included as authors on all major out-
puts. We will continue to regularly communicate with our research participants, both gather-
ing and acting on their feedback as follow-up data is collected and communicating the
findings of the study as soon as they become available.
Limitations
We did not employ a random sampling technique in this study due to resource and time con-
straints, as we needed to rapidly establish the cohort during the early stages of the pandemic to
capture vital baseline data. Our study population was self-selecting and comparison with
Welsh and UK population data from published sources indicated that our sample is not
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representative of the Welsh or UK general population in terms of their demographic profile.
Females, those of white ethnicity, and those with higher education qualifications are over-rep-
resented in the COPE cohort relative to the Welsh and UK general populations. The COPE
cohort also includes a higher proportion of people who are in the older age groups and have
pre-existing medical conditions that in the general population, and as such are at increased
risk of severe harm from COVID-19 disease, making this an important population to study.
There is variation within the COPE cohort in terms of demographic characteristics, caring
responsibilities, physical and mental health, to enable us to capture a wide range of views and
experiences, and to carry out meaningful and novel analysis with the data produced. However,
the characteristics of the cohort need to be considered during analysis of data and interpreta-
tion, particularly with regard tour ability to generalise from our findings.
The majority of the COPE cohort were recruited via HWW and were therefore resident
and/or accessing healthcare in Wales. Responsibility for healthcare is devolved to the Welsh
Government, and policy has diverged from the rest of the UK in terms of the timing and
implementation of COVID-19 infection-transmission prevention policy to fit the needs of the
local population and healthcare services [65]. Though implemented slightly differently, the
measures introduced to control the spread of COVID-19 have been broadly similar in Wales
to the rest of the UK over the course of the pandemic to date, including guidance on hygiene
and social distancing, stay at home or stay local guidelines, local lockdowns, travel restrictions,
school closures, closure of non-essential shops and services during peak infection periods,
rapid implementation of an adult vaccination program in 2021 [65]. Trust in UK Government
and Welsh Government has fluctuated over the course of the pandemic, but trust in the Welsh
Government has generally been higher than for the UK Government, which may be reflected
in the vaccine attitudes reported in the COPE study [83, 84]. The policy context in devolved
nations as well as UK-wide policy will need to be considered when interpreting our findings.
Conclusions
The COPE study enables the utilisation of a cohort with COVID specific details, linked
together in a reproducible dynamic platform approach to routine EHR data, to enable oppor-
tunities to conduct anonymised person level in-depth longitudinal analysis of health behav-
iour, subjective health and well-being, and their determinants in a large UK community
sample over the course of the COVID-19 pandemic. The socio-demographic characteristics of
this cohort and the socio-political context during data collection windows will be considered
during data analysis and interpretation of findings.
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